R. Cherian

Identification by mass spectrometry and immunoblotting of xenogeneic antigens in the N- and O-glycomes of porcine, bovine and equine heart tissues

N. Karlsson, Jining Liu, M. Breimer, 2020, Glycoconjugate Journal.

hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells

Jussi T. Koivumäki, K. Aalto-Setälä, J. Hyttinen, 2020, Cells.

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation

J. Kreutzer, M. Pekkanen-Mattila, K. Aalto-Setälä, 2022, Stem cells international.

O-glycan repertoires on a mucin-type reporter protein expressed in CHO cell pools transiently transfected with O-glycan core enzyme cDNAs.

N. Karlsson, Jining Liu, J. Holgersson, 2015, Journal of biotechnology.

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity

K. Aalto-Setälä, K. Penttinen, H. Swan, 2023, BMC Cardiovascular Disorders.

Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors

N. Karlsson, Jining Liu, J. Holgersson, 2016, Infection and Immunity.

The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity

K. Aalto-Setälä, T. Heliö, J. Koskenvuo, 2023, Biomedicines.

Recombinant Mucins with Tailored Glycosylation as Bacterial Toxin Inhibitors

R. Cherian, 2015 .